Optometrists in Bonita, CA Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Bonita Point Family Optometry, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 180 Otay Lakes Rd, Suite 201, Bonita, CA 91902 Phone: 619-267-9900 Fax: 619-267-9910 |
 Dr. Ronald B Short, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-9997 |
Dr. Daniel Cha, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4502 Bonita Rd, Bonita, CA 91902 Phone: 619-479-7334 Fax: 619-475-3456 |
Daniel Luther Mason, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 180 Otay Lakes Rd, Suite 201, Bonita, CA 91902 Phone: 619-267-9900 Fax: 619-267-9910 |
Henry E Kikunaga, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 180 Otay Lakes Rd, Suite 201, Bonita, CA 91902 Phone: 619-267-9900 Fax: 619-267-9910 |
Dr. Edward K. Harver, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4502 Bonita Rd, Bonita, CA 91902 Phone: 619-479-7334 Fax: 619-475-3456 |
News Archive
BIOTONE launches Edu-Partner Community Outreach Award Program for fifth year
BIOTONE today launched its 2011 Edu-Partner Community Outreach Award Program. Now in its fifth year, the BIOTONE program awards two massage schools $2500 grants for their community volunteer massage therapy programs conducted during the year. BIOTONE will announce the 2011 recipients in early 2012.
Review underscores the need to increase support for older subsidized housing residents with dementia
A recent scoping review, published online in the Journal of Aging and Environment, found that older adults with dementia or cognitive impairment who live in subsidized housing face complex challenges that, left unaddressed, threaten to exacerbate their health and ability to age in place.
Promising new molecular targets and treatment approaches for some of the most malignant brain tumors
The first study identified a protein that seems to control the malignant features of brain tumor cells, suggesting a new treatment target for anti-cancer drugs. Researchers found that a little-known protein called Fra-1 was effective in controlling vascular endothelial growth factor D, a factor that promotes the growth of new blood vessels in most malignant brain tumors.
Hospitalized COVID-19 patients with impaired first-phase ejection fraction have higher death risk
Hospitalized COVID-19 patients with impaired first-phase ejection fraction were nearly 5 times more likely to die compared to patients with healthier measures of this early, often undetected sign of heart failure, according to new research published today in Hypertension, an American Heart Association journal.
› Verified 3 days ago
Chiropractors
Optometrists
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Audiologists